Constellation Brands (NYSE: STZ) and Altria (NYSE: MO) are both often considered stable blue chip stocks for income investors ...

Teen vaping is decreasing, but now nicotine pouches are gaining ground.

The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the ...

The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering ...

In 2022, Altria's $12.8 billion investment in the e-cigarette maker Juul backfired as the Food and Drug Administration (FDA) banned all of its products.

The Gardenia Blue Interest Group, which petitioned the government to approve the dye, has asked the FDA to make an exemption for the dye from being labeled as an allergen due to the soy protein. Soy ...

CPEAR’s poll is a thinly veiled attempt to persuade policymakers to take a broadly popular issue in a less popular direction.

R.J. Reynolds Vapor Co.’s Vuse remains the top-selling e-cigarette brand with a 34.9% market share, while Geek Bar Pule by ...

Altria also spent nearly $13 billion in 2018 for a 35% stake in Juul, a California-based leading maker of vaping products, as part of a diversification strategy.

Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the U.S. Food and Drug Administration (FDA) approved ANDEMBRY® (garadacimab-gxii), the only treatment targeting factor XIIa ...